Your browser doesn't support javascript.
loading
PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication.
Gao, Lixia; Yang, Jie; Feng, Jutao; Liu, Ziying; Dong, Ying; Luo, Jiangyan; Yu, Liangzhentian; Wang, Jiamei; Fan, Hongying; Ma, Weifeng; Liu, Tiancai.
Affiliation
  • Gao L; Department of Microbiology, School of Public Health, Southern Medical University, Guangzhou, China.
  • Yang J; Department of Microbiology, School of Public Health, Southern Medical University, Guangzhou, China.
  • Feng J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Liu Z; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Dong Y; Institute of Antibody Engineering, School of Laboratory Medicine & Biotechnology, Southern Medical University, Guangzhou, China.
  • Luo J; Department of Microbiology, School of Public Health, Southern Medical University, Guangzhou, China.
  • Yu L; Department of Microbiology, School of Public Health, Southern Medical University, Guangzhou, China.
  • Wang J; Department of Microbiology, School of Public Health, Southern Medical University, Guangzhou, China.
  • Fan H; Department of Microbiology, School of Public Health, Southern Medical University, Guangzhou, China.
  • Ma W; Department of Microbiology, School of Public Health, Southern Medical University, Guangzhou, China.
  • Liu T; Institute of Antibody Engineering, School of Laboratory Medicine & Biotechnology, Southern Medical University, Guangzhou, China.
Front Immunol ; 13: 856463, 2022.
Article in En | MEDLINE | ID: mdl-35572586

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic / Nanoparticles / Hepatitis B Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic / Nanoparticles / Hepatitis B Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland